Stay updated on TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Inclusion criteria were standardized to 18-72 years and clarified lab and cardiac thresholds (ALT/AST ≤ 2.5× ULN; total bilirubin ≤ 1.5 mg/dL with Gilbert's syndrome exception; LVEF ≤ 45% for select patients).
    Difference
    0.5%
    Check dated 2026-04-02T15:34:26.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revised the study design to include Cohort 3 with pembrolizumab and updated treatment regimens (TIL with IL-2) and dosing; added clarifications to cohort assignments and eligibility criteria.
    Difference
    0.8%
    Check dated 2026-03-26T11:44:56.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and added MedlinePlus Genetics; updated the revision tag from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T05:24:49.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; deleted Melanoma and related topics (MedlinePlus Genetics); Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-12T02:27:38.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    - Melanoma added as a related topic and a MedlinePlus Genetics entry added to related topics.
    Difference
    0.1%
    Check dated 2026-03-04T23:54:50.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Melanoma and the related topic MedlinePlus Genetics were removed from the page.
    Difference
    0.1%
    Check dated 2026-02-25T20:27:25.000Z thumbnail image

Stay in the know with updates to TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.